Value of AAA screening drops as smoking declines
Mortality from abdominal aortic aneurysms (AAAs) has dropped sharply over the...Read more on AuntMinnie.comRelated Reading:
POCUS helps medical students find more AAAs than surgeons
USPSTF to take another look at AAA screening
Current AAA screening strategies may miss the mark
Vascular surgery society cautions use of US in AAA
USPSTF finalizes AAA screening recommendations (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 15, 2018 Category: Radiology Source Type: news
Cardinal Health deals majority stake in NaviHealth to PE shop CD & R
Cardinal Health (NYSE:CAH) said this week it divested itself of its majority stake in NaviHealth to private equity firm Clayton, Dubilier & Rice, with Cardinal Health retaining the call right to reacquire the business.
NaviHealth provides post-acute car programs to hospital systems, health planst, physician groups and healthcare providers as part of value-based care programs, Cardinal Health said.
Through the deal, CD&R will obtain a 55% ownership stake in NaviHealth, while Dublin, Ohio-based Cardinal Health will retain an approximate 45% stake in the post-acute care focused business.
“This new investment st...
Source: Mass Device - June 15, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Cardinal Health Source Type: news
Screen Does Not Cut Abdominal Aortic Aneurysm Mortality in Men
FRIDAY, June 15, 2018 -- Screening men for abdominal aortic aneurysm (AAA) does not reduce AAA-related mortality, according to a study published in the June 16 issue of The Lancet.
Minna Johansson, M.D., from the University of Gothenburg in Sweden,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 15, 2018 Category: Pharmaceuticals Source Type: news
Screening for aortic aneurysms in older men questioned
(University of Gothenburg) Screening programs for aortic aneurysms in the abdomen is now being questioned in a study published in The Lancet. As the condition becomes less common, general ultrasound scans for 65-year-old men may do more harm than good, the researchers assert. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 15, 2018 Category: International Medicine & Public Health Source Type: news
FDA panel backs Cardinal Health ’ s Incraft stent graft
Cardinal Health (NYSE:CAH) said this week that the FDA Circulatory System Devices Panel of its Medical Devices Advisory Committee issued a favorable recommendation on the premarket approval application for the company’s Incraft abdominal aortic aneurysm stent graft system.
The panel voted 11 to 4 in favor of the Incraft system, which is designed as an advanced endovascular aneurysm system for treating infrarenal abdominal aortic aneurysms, the Dublin, Ohio-based company said.
The Incraft AAA system differs from other EVAR systems as it is intended to treat a wider range of patients, as many EVAR devices are limited ...
Source: Mass Device - June 14, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Stent Grafts Vascular Cardinal Health Source Type: news
FDA Panel Backs Aortic Aneurysm Repair Device
(MedPage Today) -- Incraft stent graft system safe and effective, committee members say (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 13, 2018 Category: American Health Source Type: news
Puerto Rico Issues New Data on Hurricane Maria Deaths
SAN JUAN, Puerto Rico (AP) — Eight days after Hurricane Maria devastated Puerto Rico, Efrain Perez felt a pain in his chest.
Doctors near his small town sent him to Puerto Rico's main hospital for emergency surgery for an aortic aneurysm. But when the ambulance pulled into the parking lot in the capital, San Juan, after a more than two-hour drive, a doctor ran out to stop it.
"He said, 'Don't bring him in here, I can't care for him. I don't have power. I don't have water. I don't have an anesthesiologist,'" Perez's daughter, Nerybelle, recalled.
The 95-year-old Perez died as the ambulance drove him back to sout...
Source: JEMS: Journal of Emergency Medical Services News - June 12, 2018 Category: Emergency Medicine Authors: Danica Coto, Associated Press Tags: Major Incidents News Category Source Type: news
Cardinal Health ’ s Cordis wins date with FDA panel for Incraft AAA stent graft
Cardinal Health (NYSE:CAH) subsidiary Cordis this week won a June date with an FDA panel looking to discuss the premarket approval application for its InCraft AAA stent graft system designed for treating infrarenal abdominal aortic aneurysms.
On June 12, the FDA’s Medical Device Advisory Committee’s Circulatory Systems Devices Panel will meet to discuss possible marketing applications for the InCraft, which is currently under evaluation in the company’s Inspiration study.
The Inspiration study has already met its primary safety and effectiveness endpoints, but reported a higher than anticipated rate of certain adve...
Source: Mass Device - May 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Regulatory/Compliance Stent Grafts Vascular Cardinal Health Cordis Corp. Source Type: news
MicroPort Scientific buys Lombard Medical out of bankruptcy
Lombard Medical Technologies (NSDQ:EVAR) said today that it was acquired out of bankruptcy by MicroPort Scientific (HK:00853), which hopes to get Lombard’s stent grafts on the market in China.
MicroPort put $15 million into Lombard back in December 2016 in a deal that aimed to accelerate the commercialization of Lombard’s Aorfix and Altura stent grafts for treating abdominal aortic aneurysms. Finalized in April 2017, the agreement called for MicroPort to make components for Aorfix and Altura at its facility in Shanghai and gave it exclusive marketing rights for Lombard products in China and Brazil.
Today Oxf...
Source: Mass Device - April 26, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Stent Grafts Wall Street Beat Lombard Medical MicroPort Scientific Source Type: news
Fruit fly study identifies new gene linked to aortic aneurysms
(Baylor College of Medicine) An interdisciplinary team of researchers has identified a new gene linked to human aortic aneurysms. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 24, 2018 Category: Biology Source Type: news
Terumo ’ s Vascutek, Bolton Medical merge to form Terumo Aortic
Terumo Corp. (TYO:4543) said today its Vascutek subsidiary and Bolton Medical have merged together to form a new company, Terumo Aortic.
The newly combined company is expected to have a revenue of more than $200 million, and will employ more than 1,100 individuals worldwide, Tokyo-based Terumo said.
Terumo Aortic will look to accelerate its position in treating aortic disease, the companies said, with primary research and manufacturing facilities in Glasgow, Scotland and Sunrise, Fla.
The combined company’s portfolio will include surgical grafts for cardiothoracic, abdominal and peripheral applications and hybrid ...
Source: Mass Device - April 23, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Vascular Bolton Medical Terumo terumoaortic Source Type: news
Why you might think twice about wine with dinner
Having a single glass of wine with dinner every night could cut your life expectancy by about two years, according to an international study linking increased alcohol consumption with a higher risk of developing fatal diseases.
The research, published in the medical journal The Lancet, found that people who drank the equivalent of about six glasses of wine a week or more increased their risk of stroke, heart disease, heart failure, fatal hypertensive disease and fatal aortic aneurysm.
The researchers… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 13, 2018 Category: Biotechnology Authors: Anne Stych Source Type: news
Why you might think twice about wine with dinner
Having a single glass of wine with dinner every night could cut your life expectancy by about two years, according to an international study linking increased alcohol consumption with a higher risk of developing fatal diseases.
The research, published in the medical journal The Lancet, found that people who drank the equivalent of about six glasses of wine a week or more increased their risk of stroke, heart disease, heart failure, fatal hypertensive disease and fatal aortic aneurysm.
The researchers… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 13, 2018 Category: Pharmaceuticals Authors: Anne Stych Source Type: news
Gore wins expanded indications for Cardioform septal occluder
W.L. Gore & Associates said today it won expanded FDA indications for its Cardioform septal occluder, now cleared for the closure of patent foramen ovale to reduce the risk of recurrent ischemic stroke in certain patients.
The expanded application was supported by results from the Reduce study, which the Newark, Del.-based company said showed that closure of PFOs could significantly prevent recurrent ischemic stroke regardless of PFO anatomy.
“With the FDA approval of the Gore Cardioform septal occluder for PFO closure, we can now provide physicians with one device that can be used for both ASDs and PFOs. The val...
Source: Mass Device - April 3, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Food & Drug Administration (FDA) Regulatory/Compliance W.L. Gore & Associates Source Type: news
7 medtech stories we missed this week: March 23, 2018
[Image from unsplash.com]From Medizone’s evaluation deal to Advantis Medical Imaging getting CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning.
1. Medizone inks AsepticSure evaluation deal with commercial cleaning products maker Innovasource
Medizone announced in a March 22 press release that it has signed a product evaluation agreement with Innovasource. As part of the agreement, Innovasource will be leading the evaluation of the AsepticSure system and compare it to existing cleaning practices in a number of facilities and settings. AsepticSure is designed ...
Source: Mass Device - March 23, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Food & Drug Administration (FDA) Hospital Care Imaging Implants Patient Monitoring Regulatory/Compliance Respiratory advantismedicalimaging aziyobiologics Balt endospan Medizone MedTech Olympus Respiratory Motion Source Type: news
